[T1G3 bladder tumors: 5 years later].
We have evaluated 79 patients affected by bladder cancer T1G3: 31 underwent just endoscopy, 11 radiotherapy, 10 cystectomy and 27 topical chemotherapy. At five years 44 patients were alive and disease free, 7 were alive but recurrent in TA, 3 were alive but in metastatic progression, 17 were died because of the tumor, 3 died because of the therapy, and 5 died disease free. The authors believe that this patients could be treated with BCG as first treatment choice performing cystectomy when relapse or progression occuring.
Pegoraro
C
C
Divisione di Urologia, Azienda Ospedaliera Carlo Poma, Mantova.
Bondovalli
C
C
Dall'Oglio
B
B
Schiavon
L
L
Luciano
M
M
Parma
A
A
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D015653:Cystectomy; D018572:Disease-Free Survival; D004724:Endoscopy; D015251:Epirubicin / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D013997:Time Factors; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin
Neoplasie vescicali T1G3: 5 anni dopo.